199 related articles for article (PubMed ID: 27263438)
1. Synthesis and antiproliferative activity evaluation of steroidal imidazo[1,2-a]pyridines.
Rassokhina IV; Volkova YA; Kozlov AS; Scherbakov AM; Andreeva OE; Shirinian VZ; Zavarzin IV
Steroids; 2016 Sep; 113():29-37. PubMed ID: 27263438
[TBL] [Abstract][Full Text] [Related]
2. Steroidal N-Sulfonylimidates: Synthesis and biological evaluation in breast cancer cells.
Volkova YA; Kozlov AS; Kolokolova MK; Uvarov DY; Gorbatov SA; Andreeva OE; Scherbakov AM; Zavarzin IV
Eur J Med Chem; 2019 Oct; 179():694-706. PubMed ID: 31284080
[TBL] [Abstract][Full Text] [Related]
3. N-substituted piperazinopyridylsteroid derivatives as abiraterone analogues inhibit growth and induce pro-apoptosis in human hormone-independent prostate cancer cell lines.
Brossard D; Zhang Y; Haider SM; Sgobba M; Khalid M; Legay R; Duterque-Coquillaud M; Galera P; Rault S; Dallemagne P; Moslemi S; El Kihel L
Chem Biol Drug Des; 2013 Nov; 82(5):620-9. PubMed ID: 23906044
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of copper and zinc 2-(pyridin-2-yl)imidazo[1,2-a]pyridine complexes and their potential anticancer activity.
Dam J; Ismail Z; Kurebwa T; Gangat N; Harmse L; Marques HM; Lemmerer A; Bode ML; de Koning CB
Eur J Med Chem; 2017 Jan; 126():353-368. PubMed ID: 27907874
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological evaluation of new steroidal pyridines as potential anti-prostate cancer agents.
Shi YK; Wang B; Shi XL; Zhao YD; Yu B; Liu HM
Eur J Med Chem; 2018 Feb; 145():11-22. PubMed ID: 29310026
[TBL] [Abstract][Full Text] [Related]
6. Design and synthesis of D-ring steroidal isoxazolines and oxazolines as potential antiproliferative agents against LNCaP, PC-3 and DU-145 cells.
Banday AH; Giri AK; Parveen R; Bashir N
Steroids; 2014 Sep; 87():93-8. PubMed ID: 24910245
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and anti-tumor evaluation of novel steroidal glycoconjugate with furoxan derivatives.
Li H; Wang K; Wan Q; Chen Y
Steroids; 2019 Jan; 141():81-95. PubMed ID: 30521816
[TBL] [Abstract][Full Text] [Related]
8. Design and synthesis of new imidazo[1,2-a]pyridine and imidazo[1,2-a]pyrazine derivatives with antiproliferative activity against melanoma cells.
Garamvölgyi R; Dobos J; Sipos A; Boros S; Illyés E; Baska F; Kékesi L; Szabadkai I; Szántai-Kis C; Kéri G; Őrfi L
Eur J Med Chem; 2016 Jan; 108():623-643. PubMed ID: 26724730
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and biological evaluation of dehydroepiandrosterone-fused thiazole, imidazo[2,1-b]thiazole, pyridine steroidal analogues.
Zhang BL; Song LX; Li YF; Li YL; Guo YZ; Zhang E; Liu HM
Steroids; 2014 Feb; 80():92-101. PubMed ID: 24355392
[TBL] [Abstract][Full Text] [Related]
10. Fe(iii)-Catalyzed synthesis of steroidal imidazoheterocycles as potent antiproliferative agents.
Samanta S; Ghosh AK; Ghosh S; Ilina AA; Volkova YA; Zavarzin IV; Scherbakov AM; Salnikova DI; Dzichenka YU; Sachenko AB; Shirinian VZ; Hajra A
Org Biomol Chem; 2020 Aug; 18(29):5571-5576. PubMed ID: 32662797
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of new steroidal imidazo [1,2-a] pyridines: DNA binding studies, cleavage activity and in vitro cytotoxicity.
Dar AM; Shamsuzzaman ; Gatoo MA
Steroids; 2015 Dec; 104():163-75. PubMed ID: 26433147
[TBL] [Abstract][Full Text] [Related]
12. Novel amino substituted tetracyclic imidazo[4,5-b]pyridine derivatives: Design, synthesis, antiproliferative activity and DNA/RNA binding study.
Lončar B; Perin N; Mioč M; Boček I; Grgić L; Kralj M; Tomić S; Stojković MR; Hranjec M
Eur J Med Chem; 2021 May; 217():113342. PubMed ID: 33751978
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of imidazo[1,5-a]pyridine-benzimidazole hybrids as inhibitors of both tubulin polymerization and PI3K/Akt pathway.
Kamal A; Rao AV; Nayak VL; Reddy NV; Swapna K; Ramakrishna G; Alvala M
Org Biomol Chem; 2014 Dec; 12(48):9864-80. PubMed ID: 25354805
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and evaluation of the diarylthiourea analogs as novel anti-cancer agents.
Liu S; Louie MC; Rajagopalan V; Zhou G; Ponce E; Nguyen T; Green L
Bioorg Med Chem Lett; 2015 Mar; 25(6):1301-5. PubMed ID: 25701251
[TBL] [Abstract][Full Text] [Related]
15. Imidazopyridine-fused [1,3]-diazepinones: synthesis and antiproliferative activity.
Gallud A; Vaillant O; Maillard LT; Arama DP; Dubois J; Maynadier M; Lisowski V; Garcia M; Martinez J; Masurier N
Eur J Med Chem; 2014 Mar; 75():382-90. PubMed ID: 24561668
[TBL] [Abstract][Full Text] [Related]
16. Imidazopyridine-fused [1,3]-diazepinones part 2: Structure-activity relationships and antiproliferative activity against melanoma cells.
Bellet V; Lichon L; Arama DP; Gallud A; Lisowski V; Maillard LT; Garcia M; Martinez J; Masurier N
Eur J Med Chem; 2017 Jan; 125():1225-1234. PubMed ID: 27871038
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and cytotoxicity studies of novel pyrazolo[1, 5-a]pyridine derivatives.
Ravi C; Qayum A; Chandra Mohan D; Singh SK; Adimurthy S
Eur J Med Chem; 2017 Jan; 126():277-285. PubMed ID: 27889631
[TBL] [Abstract][Full Text] [Related]
18. Novel Pyrazolo[3,4-b]pyridine Derivatives: Synthesis, Characterization, Antimicrobial and Antiproliferative Profile.
Salem MS; Ali MA
Biol Pharm Bull; 2016; 39(4):473-83. PubMed ID: 27040621
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and QSAR study of certain isatin-pyridine hybrids as potential anti-proliferative agents.
Eldehna WM; Altoukhy A; Mahrous H; Abdel-Aziz HA
Eur J Med Chem; 2015 Jan; 90():684-94. PubMed ID: 25499988
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis, and biological evaluation of novel 3-substituted imidazo[1,2-a]pyridine and quinazolin-4(3H)-one derivatives as PI3Kα inhibitors.
Fan YH; Li W; Liu DD; Bai MX; Song HR; Xu YN; Lee S; Zhou ZP; Wang J; Ding HW
Eur J Med Chem; 2017 Oct; 139():95-106. PubMed ID: 28800461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
